Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126902522 | 12690252 | 2 | F | 20160929 | 20160826 | 20160930 | PER | PHEH2016US021445 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160930 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126902522 | 12690252 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 5 CM2, 9 MG RIVASTIGMINE BASE | U | 4305B | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126902522 | 12690252 | 1 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126902522 | 12690252 | Application site discolouration | |
126902522 | 12690252 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |